AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $668,000 | +187.9% | 8,663 | +213.5% | 0.03% | +233.3% |
| Q2 2018 | $232,000 | -64.0% | 2,763 | -65.0% | 0.01% | -65.4% |
| Q1 2018 | $644,000 | -57.2% | 7,887 | -70.1% | 0.03% | -61.2% |
| Q4 2017 | $1,505,000 | +252.5% | 26,335 | +158.1% | 0.07% | +219.0% |
| Q2 2016 | $427,000 | -64.0% | 10,202 | -65.1% | 0.02% | -60.4% |
| Q1 2016 | $1,185,000 | -42.5% | 29,202 | +33.7% | 0.05% | -25.4% |
| Q1 2015 | $2,060,000 | -66.8% | 21,848 | -60.5% | 0.07% | -69.4% |
| Q4 2014 | $6,204,000 | – | 55,377 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |